Response to Oleribe
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study on opioid use in cancer survivors found no evidence of increased persistent opioid use among Black veterans. The data does not support claims of racial disparities in opioid outcomes based on flawed comparative methodology.
Area Of Science
- Oncology
- Public Health
- Pharmacology
Background
- Persistent opioid use is a significant concern among cancer survivors.
- Understanding potential racial disparities in opioid outcomes is crucial for equitable care.
- Previous analyses have suggested racial disparities in opioid use among veteran populations.
Purpose Of The Study
- To critically evaluate a prior analysis suggesting increased persistent opioid use among Black veterans.
- To re-examine the data regarding opioid use patterns in cancer survivors, specifically focusing on racial demographics.
- To address methodological concerns in the assessment of racial disparities in opioid outcomes.
Main Methods
- Review and critique of the methodology used in a previous critical appraisal.
- Analysis of data pertaining to persistent opioid use, abuse, and toxicity.
- Comparison of opioid use proportions against relevant demographic data.
Main Results
- The methodology used in the critical appraisal was found to be flawed.
- The data does not support the conclusion of increased persistent opioid use among Black veterans.
- No statistically significant evidence was found to confirm racial disparities in opioid outcomes based on the reviewed data.
Conclusions
- The prior conclusion regarding increased persistent opioid use among Black veterans is not supported by the data.
- Methodological limitations in comparative analyses can lead to inaccurate conclusions about racial disparities.
- Further rigorous research is needed to accurately assess and address racial disparities in opioid use among cancer survivors.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...